Petros Pharm Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 5,822 | 5,992 | 7,811 |
| Cost of Goods | N/A | N/A | 1,631 | 2,289 | 1,600 |
| Gross Profit | N/A | N/A | 4,191 | 3,703 | 6,212 |
| Operating Expenses | 4,641 | 4,627 | 18,440 | 23,908 | 24,859 |
| Operating Income | -4,641 | -4,627 | -13,617 | -19,916 | -18,048 |
| Interest Expense | 0 | 0 | 536 | 596 | 369 |
| Other Income | 141 | 3,922 | 5,990 | 474 | 9,430 |
| Pre-tax Income | -4,500 | -705 | -8,163 | -20,038 | -8,987 |
| Net Income Continuous | -4,500 | -705 | -8,163 | -20,038 | -8,987 |
| Net Income Discontinuous | 6,414 | -13,614 | N/A | N/A | N/A |
| Net Income | $1,914 | $-14,319 | $-8,163 | $-20,038 | $-8,987 |
| EPS Basic Total Ops | -1.56 | -83.47 | -158.75 | -242.00 | -206.25 |
| EPS Basic Continuous Ops | -1.79 | -41.06 | -93.79 | -242.00 | -206.31 |
| EPS Basic Discontinuous Ops | 0.23 | -42.40 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1.56 | -83.47 | -158.75 | -242.00 | -206.25 |
| EPS Diluted Continuous Ops | -1.79 | -41.06 | -93.79 | -242.00 | -206.31 |
| EPS Diluted Discontinuous Ops | 0.23 | -42.40 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | -92.50 | -158.75 | N/A | -425.00 |
| EBITDA(a) | $-4,641 | $-4,627 | $-10,202 | $-6,740 | $-11,158 |